DBV DBVT Stock
DBV Price Chart
DBV DBVT Financial and Trading Overview
| DBV stock price | 15.6 USD |
| Previous Close | 15.53 USD |
| Open | 15.78 USD |
| Bid | 15.85 USD x 100 |
| Ask | 15.78 USD x 100 |
| Day's Range | 15.43 - 16.08 USD |
| 52 Week Range | 8.5 - 26.19 USD |
| Volume | 430.45K USD |
| Avg. Volume | 240.27K USD |
| Market Cap | 929.23M USD |
| Beta (5Y Monthly) | -0.218 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.5 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 39.96 USD |
DBVT Valuation Measures
| Enterprise Value | 706.07M USD |
| Trailing P/E | N/A |
| Forward P/E | -32.356236 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 161.99982 |
| Price/Book (mrq) | 4.466572 |
| Enterprise Value/Revenue | 123.095 |
| Enterprise Value/EBITDA | -4.275 |
Trading Information
DBV Stock Price History
| Beta (5Y Monthly) | -0.218 |
| 52-Week Change | 81.42% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 26.19 USD |
| 52 Week Low | 8.5 USD |
| 50-Day Moving Average | 19.08 USD |
| 200-Day Moving Average | 17.61 USD |
DBVT Share Statistics
| Avg. Volume (3 month) | 240.27K USD |
| Avg. Daily Volume (10-Days) | 283.37K USD |
| Shares Outstanding | 59.19M |
| Float | 35.25M |
| Short Ratio | 7.31 |
| % Held by Insiders | 0% |
| % Held by Institutions | 37.23% |
| Shares Short | 1.67M |
| Short % of Float | 2.81% |
| Short % of Shares Outstanding | 2.81% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -5311.11% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -66.35% |
| Return on Equity (ttm) | -158.88% |
Income Statement
| Revenue (ttm) | 5.74M USD |
| Revenue Per Share (ttm) | 0.13 USD |
| Quarterly Revenue Growth (yoy) | 12.50% |
| Gross Profit (ttm) | 5.74M USD |
| EBITDA | -165162000 USD |
| Net Income Avi to Common (ttm) | -167447008 USD |
| Diluted EPS (ttm) | -4.53 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 229.2M USD |
| Total Cash Per Share (mrq) | 3.87 USD |
| Total Debt (mrq) | 6.1M USD |
| Total Debt/Equity (mrq) | 2.93 USD |
| Current Ratio (mrq) | 4.763 |
| Book Value Per Share (mrq) | 3.515 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -150580992 USD |
| Levered Free Cash Flow (ttm) | -87206000 USD |
Profile of DBV
| Country | United States |
| State | N/A |
| City | Châtillon |
| Address | BAtiment IRO |
| ZIP | 92320 |
| Phone | 33 1 55 42 78 78 |
| Website | https://www.dbv-technologies.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 161 |
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. The company's earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.
Q&A For DBV Stock
What is a current DBVT stock price?
DBV DBVT stock price today per share is 15.6 USD.
How to purchase DBV stock?
You can buy DBVT shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for DBV?
The stock symbol or ticker of DBV is DBVT.
Which industry does the DBV company belong to?
The DBV industry is Biotechnology.
How many shares does DBV have in circulation?
The max supply of DBV shares is 59.19M.
What is DBV Price to Earnings Ratio (PE Ratio)?
DBV PE Ratio is now.
What was DBV earnings per share over the trailing 12 months (TTM)?
DBV EPS is -4.5 USD over the trailing 12 months.
Which sector does the DBV company belong to?
The DBV sector is Healthcare.
DBV DBVT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25476.64 USD — |
-0.43
|
14.18B USD — | 25354.66 USD — | 25840.56 USD — | — - | 14.18B USD — |
|
US Tech Biotechnology Total Retu
XNBI
US
|
6853.11 USD — |
+1.52
|
— — | 6790.49 USD — | 6916.92 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12494.8 USD — |
-0.42
|
— — | 12434.7 USD — | 12673.39 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1203.64 USD — |
+1.6
|
— — | 1192.12 USD — | 1213.64 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
31424.39 USD — |
-0.43
|
— — | 31273.93 USD — | 31873.27 USD — | — - | — — |
- {{ link.label }} {{link}}